Stock listing

ARTL Stock Price, News, Filings & Events — Artelo Biosciences, Inc.

Selected listing: ARTL · BOATS · USD · US

This page tracks Artelo Biosciences, Inc.'s ARTL:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARTL:BOATS. ARTL:BOATS is the stock-level entry point for investors researching Artelo Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Artelo Biosciences, Inc. is a public company traded under the ticker ARTL in the American market. The company has a market capitalization of approximately $3.56 million. Artelo focuses on developing innovative therapies, particularly in the field of cannabinoid-based treatments.

ARTL:BOATSUSDUSUpdated August 14, 2026
Artelo Biosciences, Inc. logo
Ticker
ARTL:BOATS
Asset type
Stock
Market cap
$3.6M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Artelo Biosciences, Inc. ARTL:BOATS stock context

This page tracks Artelo Biosciences, Inc.'s ARTL:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARTL:BOATS. ARTL:BOATS is the stock-level entry point for investors researching Artelo Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Artelo Biosciences, Inc. is a public company traded under the ticker ARTL in the American market. The company has a market capitalization of approximately $3.56 million. Artelo focuses on developing innovative therapies, particularly in the field of cannabinoid-based treatments.

Research Artelo Biosciences, Inc.

Alternate listings